| scholarly article | Q13442814 |
| P50 | author | David A. Savitz | Q5230516 |
| Scott M Bartell | Q42729989 | ||
| Gregory A Wellenius | Q56246737 | ||
| Hyeong-Moo Shin | Q57945404 | ||
| P2093 | author name string | Deborah J Watkins | |
| Tony Fletcher | |||
| Veronica M Vieira | |||
| Beth Elston | |||
| Jyoti Josson | |||
| P2860 | cites work | Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability | Q23924062 |
| Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA) | Q24632957 | ||
| Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia | Q24633826 | ||
| Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population | Q24633846 | ||
| Perfluoroalkyl chemicals and elevated serum uric acid in US adults | Q24635118 | ||
| The C8 health project: design, methods, and participants | Q24652791 | ||
| Perfluoroalkyl chemicals and chronic kidney disease in US adults | Q28393763 | ||
| How Many Imputations are Really Needed? Some Practical Clarifications of Multiple Imputation Theory | Q29041019 | ||
| Prevalence of chronic kidney disease in the United States | Q29614191 | ||
| Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES). | Q31109567 | ||
| Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. | Q33702676 | ||
| The toxicology of perfluorooctanoate | Q34343282 | ||
| Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters | Q34571004 | ||
| Perfluoroalkyl acids: a review of monitoring and toxicological findings | Q34630884 | ||
| Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers | Q34680365 | ||
| Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. | Q35008916 | ||
| Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project | Q35049761 | ||
| National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification | Q35141279 | ||
| Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project | Q35682907 | ||
| Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community | Q35874820 | ||
| Relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother-child pairs in a population with perfluorooctanoate exposure from drinking water | Q35941864 | ||
| Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults | Q37139485 | ||
| Predictors of PFOA levels in a community surrounding a chemical plant. | Q37278944 | ||
| Alteration of microvascular permeability in acute kidney injury | Q37304519 | ||
| Invited Commentary: Causal diagrams and measurement bias | Q37395428 | ||
| Measurement and estimation of GFR in children and adolescents | Q37612658 | ||
| Renal elimination of perfluorocarboxylates (PFCAs). | Q37943842 | ||
| Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with age of puberty among children living near a chemical plant | Q39189165 | ||
| Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington Works Facility in West Virginia. | Q39794547 | ||
| Alterations in cell membrane properties caused by perfluorinated compounds | Q40643223 | ||
| Ammonium perfluorooctanoate production and occupational mortality | Q43268281 | ||
| A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA). | Q43279026 | ||
| Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008. | Q43745356 | ||
| Thirty years of medical surveillance in perfluooctanoic acid production workers | Q46118153 | ||
| Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis | Q46460012 | ||
| Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers | Q46608357 | ||
| Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000-2010. | Q50511791 | ||
| Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi | Q79267289 | ||
| Cardiovascular disease in patients with chronic kidney disease | Q84563746 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | teenager | Q1492760 |
| P304 | page(s) | 625-30 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Environmental Health Perspectives | Q1345904 |
| P1476 | title | Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant | |
| P478 | volume | 121 |
| Q37674896 | A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes |
| Q92648138 | Acute PFOA exposure promotes epigenomic alterations in mouse kidney tissues |
| Q57705270 | Assessment of Urinary Metabolite Excretion After Rat Acute Exposure to Perfluorooctanoic Acid and Other Peroxisomal Proliferators |
| Q28394440 | Association between perfluoroalkyl acids and kidney function in a cross-sectional study of adolescents |
| Q58080051 | Associations between longitudinal serum perfluoroalkyl substance (PFAS) levels and measures of thyroid hormone, kidney function, and body mass index in the Fernald Community Cohort |
| Q36350881 | Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK) |
| Q33654524 | Biomarker-based calibration of retrospective exposure predictions of perfluorooctanoic acid. |
| Q92619750 | Causal inference for the effect of environmental chemicals on chronic kidney disease |
| Q38367324 | Challenges for environmental epidemiology research: are biomarker concentrations altered by kidney function or urine concentration adjustment? |
| Q60921076 | Changes in hepato-renal gene expression in microminipigs following a single exposure to a mixture of perfluoroalkyl acids |
| Q47789399 | Early Pregnancy Perfluoroalkyl Substance Plasma Concentrations and Birth Outcomes in Project Viva: Confounded by Pregnancy Hemodynamics? |
| Q39447927 | Environmental exposures and pediatric kidney function and disease: A systematic review |
| Q39400487 | Exposure to Perfluorinated Alkyl Substances and Health Outcomes in Children: A Systematic Review of the Epidemiologic Literature |
| Q47287240 | Identification of Biomarkers of Exposure to FTOHs and PAPs in Humans Using a Targeted and Nontargeted Analysis Approach |
| Q40533182 | Impacts of geocoding uncertainty on reconstructed PFOA exposures and their epidemiological association with preeclampsia |
| Q38910228 | Involvement of mitogen-activated protein kinase and NF-κB signaling pathways in perfluorooctane sulfonic acid-induced inflammatory reaction in BV2 microglial cells |
| Q36095017 | Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah African Americans in South Carolina: 2003-2013. |
| Q37158816 | Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid-Ohio Valley Community |
| Q89819193 | Oxidant stress and renal function among children with chronic kidney disease: a repeated measures study |
| Q88735298 | PFOA and ulcerative colitis |
| Q100444139 | Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research |
| Q57293921 | Perfluorinated Chemicals as Emerging Environmental Threats to Kidney Health: A Scoping Review |
| Q97526919 | Pregnancy-induced changes in serum concentrations of perfluoroalkyl substances and the influence of kidney function |
| Q57144626 | Prenatal Exposure to Perfluoroalkyl Substances: Infant Birth Weight and Early Life Growth |
| Q62086877 | Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food |
| Q54993802 | Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA). |
| Q28397401 | The effects of environmental chemicals on renal function |
Search more.